PI3K
-
Qiagen Acquires License for Key PI3K Gene
Qiagen has announced that its wholly owned subsidiary DxS has acquired the global and exclusive license for biomarker PI3K from Johns Hopkins University, to develop real-time Polymerase Chain Reaction (RT-PCR) and endpoint PCR assays. Research has sh…
PI3K | 26 February 2010
